APA
Click to copy
Franke, K., Kalucka, J., Mamlouk, S., Singh, R., Muschter, A., Weidemann, A., … Wielockx, B. (2013). HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis. Blood.
Chicago/Turabian
Click to copy
Franke, K., Joanna Kalucka, S. Mamlouk, R. Singh, A. Muschter, A. Weidemann, Vasuprada Iyengar, et al. “HIF-1α Is a Protective Factor in Conditional PHD2-Deficient Mice Suffering from Severe HIF-2α-Induced Excessive Erythropoiesis.” Blood (2013).
MLA
Click to copy
Franke, K., et al. “HIF-1α Is a Protective Factor in Conditional PHD2-Deficient Mice Suffering from Severe HIF-2α-Induced Excessive Erythropoiesis.” Blood, 2013.
BibTeX Click to copy
@article{k2013a,
title = {HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.},
year = {2013},
journal = {Blood},
author = {Franke, K. and Kalucka, Joanna and Mamlouk, S. and Singh, R. and Muschter, A. and Weidemann, A. and Iyengar, Vasuprada and Jahn, Steffen and Wieczorek, K. and Geiger, K. and Muders, M. and Sykes, A. and Poitz, D. and Ripich, T. and Otto, T. and Bergmann, S. and Breier, G. and Baretton, G. and Fong, G. and Greaves, D. and Bornstein, S. and Chavakis, T. and Fandrey, J. and Gassmann, M. and Wielockx, B.}
}
Erythropoiesis must be tightly balanced to guarantee adequate oxygen delivery to all tissues in the body. This process relies predominantly on the hormone erythropoietin (EPO) and its transcription factor hypoxia inducible factor (HIF). Accumulating evidence suggests that oxygen-sensitive prolyl hydroxylases (PHDs) are important regulators of this entire system. Here, we describe a novel mouse line with conditional PHD2 inactivation (cKO P2) in renal EPO producing cells, neurons, and astrocytes that displayed excessive erythrocytosis because of severe overproduction of EPO, exclusively driven by HIF-2α. In contrast, HIF-1α served as a protective factor, ensuring survival of cKO P2 mice with HCT values up to 86%. Using different genetic approaches, we show that simultaneous inactivation of PHD2 and HIF-1α resulted in a drastic PHD3 reduction with consequent overexpression of HIF-2α-related genes, neurodegeneration, and lethality. Taken together, our results demonstrate for the first time that conditional loss of PHD2 in mice leads to HIF-2α-dependent erythrocytosis, whereas HIF-1α protects these mice, providing a platform for developing new treatments of EPO-related disorders, such as anemia.
